Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

BRISBANE, Calif., March 6, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in the following healthcare investor conferences in March:

    --  Cowen 39(th) Annual Health Care ConferencePresentation Date: Tuesday,
        March 12(th) at 8:40 a.m. Eastern TimeLocation: Boston, MA

    --  Barclays 2019 Global Healthcare ConferencePresentation Date: Thursday,
        March 14(th) at 8:00 a.m. Eastern TimeLocation: Miami, FL

    --  ARM 7(th) Annual Cell & Gene Investor DayPresentation Date: Thursday,
        March 21(st) at 2:45 p.m. Eastern TimeLocation: New York, NY

The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the events.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit

View original content to download multimedia:

SOURCE Sangamo Therapeutics, Inc.